Search filters

List of works by Joseph L Kuti

1398. β-Lactam Probability of Target Attainment (PTA) and Penetration into Epithelial Lining Fluid (ELF) Based on Multiple Bronchoalveolar Lavage (BAL) Sampling Time Points in a Swine Pneumonia Model

A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales

scientific article published on 24 June 2019

A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit

scientific article published on 01 April 2007

Acute Physiology and Chronic Health Evaluation II Score Is a Better Predictor of Mortality than IBMP-10 in Patients with Ventilator-Associated Pneumonia ⬇️

scientific article published on October 17, 2011

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

scientific article published on 17 December 2015

Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae

scientific article published on 26 June 2018

Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection

scientific article published on 23 September 2019

Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric Devices

scientific article published on 02 March 2020

Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration

scientific article published on 07 September 2019

Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults

scientific article published on 21 September 2009

Bronchopulmonary disposition of micafungin in healthy adult volunteers

scientific article

Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents

scientific article published on 26 July 2019

Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.

scientific article

Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.

scientific article published on 17 October 2016

Clinical and economic benefits of a meropenem dosage strategy based on pharmacodynamic concepts.

scientific article published in June 2004

Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae

scientific article published on 29 September 2014

Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital

scientific article published on April 2002

Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness

scientific article

Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia

scientific article published on 16 December 2013

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa

scientific article

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

scientific article published on 16 February 2007

Clostridium difficile infection--not just a burden anymore.

scientific article published on August 2009

Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

scientific article published on 6 November 2017

Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model ⬇️

scientific article published on September 13, 2010

Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5‐Minute Infusion versus the Standard 30‐Minute Infusion in Healthy Adult Volunteers ⬇️

scientific article published on February 11, 2013

Comparative pharmacodynamics for intravenous antibiotics against Gram-negative bacteria in Europe between 2002 and 2006: a report from the OPTAMA program

scientific article

Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance

scientific article published on 3 February 2009

Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods

scientific article published on 19 May 2010

Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem

scientific article published in July 2005

Comparison of probability of target attainment calculated by Monte Carlo simulation with meropenem clinical and microbiological response for the treatment of complicated skin and skin structure infections

scientific article

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model

scientific article published on 7 December 2009

Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies ⬇️

scientific article published on November 1, 2010

Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261-269]

scientific article published on 16 October 2018

Cost analysis of continuous versus intermittent infusion of piperacillin-tazobactam: a time-motion study

scientific article

Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance

scientific article

Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections

scientific article published on December 2008

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.

scientific article published on 14 December 2015

Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window

scientific article published on 28 June 2017

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints.

scientific article

Derivation of meropenem dosage in patients receiving continuous veno-venous hemofiltration based on pharmacodynamic target attainment

scientific article published on 28 June 2005

Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections Using In Vivo Microdialysis ⬇️

scientific article published on June 27, 2011

Development of an HPLC Method for the Determination of Anidulafungin in Human Plasma and Saline ⬇️

scientific article published on 01 May 2011

Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures

scientific article published in July 2013

Economic benefit of a meropenem dosage strategy based on pharmacodynamic concepts.

scientific article published in March 2003

Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins

scientific article published on 22 November 2019

Effects of Clinically Meaningful Concentrations of Antipseudomonal β-Lactams on Time to Detection and Organism Growth in Blood Culture Bottles

scientific article published on 11 October 2017

Efficacy of Human-Simulated Exposures of Ceftolozane-Tazobactam Alone and in Combination with Amikacin or Colistin against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model

scientific article published on 26 April 2018

Elevated vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus isolated from patients with ventilator-associated pneumonia at a Connecticut hospital.

scientific article

Emerging Pseudomonas aeruginosa resistance: implications in clinical practice.

scientific article published on January 2004

Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation

scientific article published on 01 May 2007

Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy

scientific article published in November 2004

Erratum for Asempa et al., "In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa"

scientific article published on 21 April 2020

Evaluating empiric treatment options for secondary peritonitis using pharmacodynamic profiling

scientific article published on April 2007

Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-0

scientific article published on 28 June 2019

Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles ⬇️

scientific article published on November 23, 2008

Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States

scientific article

Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model

scientific article published on 02 November 2020

Impact of Intraoperative Cell Salvage on Concentrations of Antibiotics used for Surgical Prophylaxis

scientific article published on 02 November 2020

Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes

scientific article published on 27 May 2014

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study

scientific article

Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia

scientific article published on 06 February 2009

In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa

scientific article published on 23 August 2019

In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase ⬇️

scientific article published on January 31, 2011

In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus ⬇️

scientific article published on October 17, 2011

In Vitro Pharmacodynamics of a Novel Ceftibuten-Clavulanate Combination Antibiotic against Enterobacteriaceae

scientific article published on 24 June 2019

In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.

scientific article

In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus

scientific article published on 6 October 2014

In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure

scientific article published on 11 November 2013

In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii ⬇️

scientific article published on May 24, 2013

In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii

scientific article published on 25 November 2013

In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers

scientific article published on 08 September 2008

Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator‐Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback ⬇️

scientific article published on August 1, 2012

Influence of automated screening and confirmation of extended-spectrum beta-lactamase-producing members of the Enterobacteriaceae on prescribing of antibiotics

scientific article

Intra-abdominal infections: considerations for the use of the carbapenems

scientific article published on February 2007

Is One Sample Enough? β-Lactam Target Attainment and Penetration into Epithelial Lining Fluid Based on Multiple Bronchoalveolar Lavage Sampling Time Points in a Swine Pneumonia Model

scientific article published on 29 January 2019

Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia

scientific article published on May 2010

Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy

scientific article published on 01 January 2011

Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia

scientific article published on 24 March 2020

Making the most of surveillance studies: summary of the OPTAMA Program

scientific article published in December 2005

Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations

scientific article published on 24 February 2018

Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis

scientific article published on May 2015

Monte Carlo Simulation Methodologies for β-Lactam/β-Lactamase Inhibitor Combinations: Effect on Probability of Target Attainment Assessments

scientific article published on 18 August 2019

Novel Pharmacotherapy for the Treatment of Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Resistant Gram-Negative Bacteria

scientific article published on 7 February 2018

Optimal cefepime and meropenem dosing for ventilator-associated pneumonia patients with reduced renal function: an update to our clinical pathway

scientific article published in March 2010

Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?

scientific article published in November 2007

Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals

scientific article published on 01 November 2006

Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance

scientific article published on January 2006

Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance

scientific article published on 17 December 2015

Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia

scientific article published on July 12, 2011

Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002.

scientific article

Patient Preferences in the Emergency Department (ED) Before Treatment for Acute Bacterial Skin and Skin Structure Infection (ABSSSI).

scientific article published on 4 October 2017

Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals

scientific article

Pharmacodynamic evaluation of meropenem and cefotaxime for pediatric meningitis: a report from the OPTAMA program

scientific article published on 01 January 2006

Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program

scientific article

Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program

scientific article published in January 2005

Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States

scientific article published in April 2010

Pharmacodynamic performance of tigecycline versus common intravenous antibiotics for the empiric treatment of complicated skin and skin structure infections

scientific article published in February 2008

Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis

scientific article published in September 2002

Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children

scientific article published in January 2008

Pharmacodynamic target attainment of seven antimicrobials against Gram-negative bacteria collected from China in 2003 and 2004.

scientific article published on 23 July 2007

Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.

scientific article published in March 2007

Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.

scientific article published on 7 May 2009

Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program

scientific article

Pharmacodynamics of antimicrobials: treatment optimisation

scientific article published on October 2005

Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa

scientific article published in January 2004

Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections

scientific article published in January 2004

Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral

scientific article published in November 2002

Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection

scientific article published on 01 April 2006

Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients

scientific article published on 23 October 2018

Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis

scientific article

Pharmacokinetics and Monte Carlo Simulations of Doripenem in Patients with Febrile Neutropenia ⬇️

scientific article published on September 25, 2012

Pharmacokinetics and Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers

scientific article published on 11 September 2017

Pharmacokinetics of Intravenous Linezolid in Moderately to Morbidly Obese Adults ⬇️

scientific article published on December 17, 2012

Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic Fibrosis ⬇️

scientific article published on April 25, 2011

Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation

scientific article published on 20 December 2019

Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit

scientific article

Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration

scientific article published on 28 December 2017

Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.

scientific article published in January 2018

Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration

scientific article published on 12 June 2018

Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration ⬇️

scientific article published on 01 December 2011

Polymyxins: older antibiotics for a new threat.

scientific article

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation

scientific article published on 22 August 2016

Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery

scientific article published on 7 December 2016

Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI).

scientific article

Population Pharmacokinetics of Piperacillin/Tazobactam in Critically Ill Young Children ⬇️

scientific article published on February 1, 2014

Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients

scientific article published on 01 October 2006

Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients

scientific article published in January 2006

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

scientific article published on 7 July 2005

Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis

scientific article

Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa ⬇️

scientific article published on December 29, 2011

Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients

scientific article

Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children

scientific article

Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia

scientific article published in November 2009

Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation

scientific article

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers ⬇️

scientific article published on February 13, 2012

Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosa.

scientific article

Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection

scientific article

Recovery of Gram-Negative Bacteria from Aerobic Blood Culture Bottles Containing Antibiotic Binding Resins after Exposure to β-Lactam and Fluoroquinolone Concentrations

scientific article published on 24 September 2019

Reevaluation of current susceptibility breakpoints for Gram-negative rods based on pharmacodynamic assessment.

scientific article published on 9 March 2007

Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae

scientific article

Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa

scientific article

Role of pharmacodynamics in designing dosage regimens for beta-lactams

scientific article

Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species

scientific article

Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function

scientific article published on 21 December 2016

Simulation of antibiotic pharmacodynamic exposure for the empiric treatment of nosocomial bloodstream infections: a report from the OPTAMA program

scientific article

Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.

scientific article published on September 2014

Surgical site infections: does inadequate antibiotic therapy affect patient outcomes?

scientific article

Tackling empirical antibiotic therapy for ventilator-associated pneumonia in your ICU: guidance for implementing the guidelines

scientific article published on 06 February 2009

The Effect of Clinical Concentrations of Meropenem (MEM), Ceftolozane/tazobactam (C/T), and Ceftazidime/avaibactam (CZA) on Time to Detection (TTD) and Growth of Pseudomonas aeruginosa (PSA) in bioMerieux BacT/ALERT®FA Plus Blood Culture (BC) Bottle

scientific article published on 4 October 2017

The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe

scientific article published in December 2004

The authors reply

The clinical and economic benefits of administering piperacillin-tazobactam by continuous infusion

scientific article

The current state of multidrug-resistant gram-negative bacilli in North America

scientific article published on February 2008

Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis ⬇️

scientific article published on October 4, 2010

Tissue penetration and exposure of cefepime in patients with diabetic foot infections.

scientific article

Treatment of Clostridium difficile-associated disease (CDAD).

scientific article

Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem

scientific article published in May 2007

Update on daptomycin: the first approved lipopeptide antibiotic

scientific article published on July 2006

Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA program

scientific article published in November 2005

Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae

scientific article published in October 2009

Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections

scientific article published on 22 March 2015

Variability in Emergency Medicine (EM) Provider Decisions on Hospital Admission and Antibiotic (ABX) Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI).

scientific article published on 4 October 2017

Variability in Emergency Medicine Provider Decisions on Hospital Admission and Antibiotic Treatment in a Survey Study for Acute Bacterial Skin and Skin Structure Infections: Opportunities for Antimicrobial Stewardship Education

article published in 2018

When "S" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection

scientific article

Where should antibiotic gradient diffusion strips be crossed to assess synergy? A comparison of the standard method with a novel method using steady-state antimicrobial concentrations

scientific article published on 14 March 2019

Paulina is supported by:

About Paulina

Help